Schroder European Alpha Plus Fund A Income GBPRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.4 | 6.3 | -15.4 | 6.5 | -4.1 | |
+/-Cat | -7.0 | -9.1 | -6.6 | -7.0 | -7.0 | |
+/-B’mrk | -5.5 | -11.0 | -7.9 | -8.5 | -7.4 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 28/03/2024 | GBP 1.59 | |
Day Change | -0.13% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB0033302760 | |
Fund Size (Mil) 28/03/2024 | GBP 54.91 | |
Share Class Size (Mil) 28/03/2024 | GBP 0.02 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 1.71% |
Investment Objective: Schroder European Alpha Plus Fund A Income GBP |
The Fund aims to provide capital growth in excess of the FTSE World Series Europe ex UK (Gross Total Return) index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of European companies, excluding the UK. The Fund is actively managed and invests at least 80% of its assets in a concentrated range of equity and equity related securities of European countries, excluding the UK. The Fund typically holds 35 to 60 companies. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Hannah Piper 01/04/2020 | ||
Inception Date 06/10/2003 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Schroder European Alpha Plus Fund A Income GBP | 30/11/2023 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 4.95 |
Befesa SA Bearer Shares | Industrials | 4.54 |
Nestle SA | Consumer Defensive | 4.51 |
Novo Nordisk A/S Class B | Healthcare | 4.48 |
Roche Holding AG | Healthcare | 4.06 |
Increase Decrease New since last portfolio | ||
Schroder European Alpha Plus Fund A Income GBP |